register

News - MedTech & Diagnostics

ParagonCare welcomes new strategic partnership

Health Industry Hub | February 22, 2024 |

MedTech & Diagnostics News: A trailblazer in AI-driven healthcare solutions has unveiled a strategic partnership with ParagonCare, a medtech company across Australia, New Zealand, and Asia. This collaboration is poised to supercharge the distribution and sales of AIRS Medical’s flagship innovation, SwiftMR, throughout Australia, leveraging ParagonCare’s robust networks.

SwiftMR stands at the forefront of medical imaging technology, employing cutting-edge deep learning algorithms to dramatically enhance the quality of MRI images. This product promises to halve MRI scan durations while concurrently elevating image clarity through sophisticated AI-powered denoising and sharpening techniques.

The technology boasts universal compatibility with MRI scanners of 3.0T or lower, irrespective of manufacturer, encompassing all body parts and pulse sequences. This innovation heralds a new era in MRI productivity, offering superior outcomes without necessitating alterations to existing workflows or the acquisition of new equipment.

Hyeseong Lee, CEO of AIRS Medical, expressed enthusiasm about the partnership, stating, “Our strategic alliance with ParagonCare is a significant milestone for AIRS Medical. Together, we are poised to accelerate our growth and enhance our operational capabilities in the ANZ region. This partnership leverages ParagonCare’s industry-leading expertise and capabilities, setting the stage for SwiftMR to revolutionise the Australian market.”

2024 marks a pivotal year for ParagonCare as it zeroes in on the AI sector, aiming to disrupt the healthcare AI market through this synergistic collaboration with AIRS Medical. This partnership underscores a shared vision between the two companies to refine patient experiences and streamline healthcare workflows through technological innovation. With SwiftMR already making significant inroads in over 15 countries, boasting more than 1.1 million processed exams across 300+ institutions, this partnership is set to catapult the technology to new heights.

Echoing this sentiment, Tiffany Chiew, General Manager Service, Technology and Innovation at ParagonCare, highlighted the collaborative ethos of the venture, remarking “We are fully committed to supporting AIRS Medical’s expansion efforts in Australia, New Zealand, Asia, and beyond. This collaboration epitomises our dedication to healthcare excellence, marrying innovation with our unwavering commitment to advancing healthcare outcomes.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News - MedTech & Diagnostics

Hearts4heart takes aim at private system leaving patients to pay the price

Hearts4heart takes aim at health insurers leaving patients to pay the price

Health Industry Hub | September 4, 2026 |

Persistent advocacy by patient groups has prompted the Medical Services Advisory Committee (MSAC) to review the funding gaps for pulsed […]

More


News - MedTech & Diagnostics

Queensland first: Private hospital deploys Abbott's PFA in atrial fibrillation

Queensland first: Private hospitals deploy Abbott’s PFA in atrial fibrillation

Health Industry Hub | September 4, 2026 |

More Australians living with atrial fibrillation (AF) are gaining access to one of the latest advances in heart-rhythm treatment, with […]

More


News - Pharmaceuticals

Five years of HTA reform talk, Now comes the $47 billion question

Five years of HTA reform talk, now comes the $47 billion question

Health Industry Hub | September 4, 2026 |

Medicines Australia has put a $47 billion price tag on what it says Australia must invest to improve equitable access […]

More


News - Pharmaceuticals

New MFN deals raise the stakes for Australia’s delayed HTA reform

New MFN deals raise the stakes for Australia’s delayed HTA reform

Health Industry Hub | September 2, 2026 |

Four months after the US Trump administration concluded what was expected to be the final tranche of drug-pricing agreements with […]

More


This content is copyright protected. Please subscribe to gain access.